Democratic Republic of the Congo

Status: affected by circulating vaccine-derived poliovirus

The Democratic Republic of the Congo has not reported a case of wild poliovirus since 2011, however, the country is affected by circulating vaccine derived poliovirus. To stop transmission, it is essential for momentum to be maintained to reach every child with polio vaccines and to strengthen disease surveillance.

Polio this week in Central Africa

  • No new cases of type 2 circulating vaccine-derived poliovirus (cVDPV2) were reported this week in the Democratic Republic of the Congo (DRC). The total number of cVDPV2 cases this year is ten.
  • Most cases this year are linked to an outbreak in Haut Lomami province, where the onset of paralysis of the most recent case was 27 July.
  • A separate outbreak occurred in Maniema province earlier this year, consisting of two cases with onset of paralysis on 26 March and 18 April, with an additional isolate detected in a healthy individual with sample collection on 2 May.
  • Outbreak response continues to take place across the country, including use of monovalent oral polio vaccine type 2 (mOPV2) in line with internationally-agreed outbreak response protocols.
  • Immunization activities scheduled this month intend to vaccinate over 10 million children with bOPV vaccine.
  • Surveillance and immunization activities continue to be strengthened in neighbouring countries.
  • Read the latest polio update from the DRC to see information on surveillance and vaccination campaigns.

International Health Regulations

The Democratic Republic of the Congo is classified by the International Health Regulations (IHR) as a state infected with cVDPV2, with potential risk of international spread.  It is therefore subject to temporary recommendations as of August 2017.

loading map...
Key at-risk: no longer poliovirus-infected, but at high risk of outbreaks
Outbreak: has stopped indigenous WPV circulation but affected by outbreak of imported WPV or circulating vaccine-derived poliovirus
Endemic: has never stopped indigenous wild poliovirus (WPV) circulation

Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

More on vaccine-derived polioviruses